Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
Morry Silberstein
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)MedicineVitamin D and neurologyLimitingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakClinical trialInternal medicineDiseaseVirologyOutbreakInfectious disease (medical specialty)Mechanical engineeringEngineeringVitamin D Research StudiesVitamin C and Antioxidants ResearchCOVID-19 Clinical Research Studies